drugset / Trial / NCT00529282
A Study of Ceftobiprole in Patients With Fever and Neutropenia.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety and efficacy of ceftobiprole versus a comparator in patients with fever and neutropenia
Timeline
- Start
- 2007-10
- Primary completion
- 2008-01
- Completion
- 2008-01
Outcome
Outcome not reported
Stopped: “Study discontinued due to administrative reasons unrelated to safety”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cefepime | Small molecule | 2 g | — |
| Subject | Ceftobiprole | Small molecule | 500 mg | — |
| Comparator | Vancomycin | Other / unclassified | 1000 mg | — |